International Assets Investment Management LLC Has $877.39 Million Holdings in The Clorox Company (NYSE:CLX)

International Assets Investment Management LLC lifted its holdings in shares of The Clorox Company (NYSE:CLX) by 424.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 538,576 shares of the company’s stock after purchasing an additional 435,971 shares during the period. International Assets Investment Management LLC’s holdings in Clorox were worth $877,390,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of CLX. Van ECK Associates Corp raised its stake in Clorox by 1,715.5% during the second quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock worth $199,411,000 after buying an additional 1,380,724 shares during the last quarter. Nuance Investments LLC raised its stake in Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after buying an additional 960,094 shares during the last quarter. Wulff Hansen & CO. raised its stake in Clorox by 13,547.0% during the second quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock worth $60,063,000 after buying an additional 436,891 shares during the last quarter. Acadian Asset Management LLC raised its stake in Clorox by 26.5% during the first quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock worth $135,099,000 after buying an additional 184,847 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its stake in Clorox by 14.4% during the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock worth $131,200,000 after buying an additional 120,716 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Down 0.1 %

CLX opened at $159.04 on Thursday. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The firm has a market capitalization of $19.75 billion, a PE ratio of 82.40, a P/E/G ratio of 3.19 and a beta of 0.41. The company’s 50-day moving average is $160.25 and its 200 day moving average is $145.43.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. The company had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. As a group, research analysts predict that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.07%. Clorox’s dividend payout ratio (DPR) is 252.85%.

Analysts Set New Price Targets

CLX has been the subject of a number of analyst reports. TD Cowen initiated coverage on shares of Clorox in a research note on Tuesday, July 23rd. They set a “sell” rating and a $122.00 target price for the company. Barclays lifted their target price on shares of Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a research note on Friday, October 11th. DA Davidson reiterated a “neutral” rating and set a $153.00 price objective on shares of Clorox in a report on Friday, September 6th. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $150.14.

Insider Buying and Selling at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.51% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.